Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent
Open Access
Abstract
Penfluridol has robust antipsychotic efficacy and is a first-generation diphenylbutylpiperidine. Its effects last for several days after a single oral dose and it can be administered once a week to provide better compliance and symptom control. Recently; strong antitumour effects for penfluridol were discovered in various cancer cell lines; such as breast; pancreatic; glioblastoma; and lung cancer cells via several distinct mechanisms. Therefore; penfluridol has drawn much attention as a potentially novel anti-tumour agent. In addition; the anti-cancer effects of penfluridol have been demonstrated in vivo: results showed slight changes in the volume and weight of organs at doses tested in animals. This paper outlines the potential for penfluridol to be developed as a next-generation anticancer drug.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2017R1A2A1A05000878, NRF-2018R1A5A2023127)
This publication has 99 references indexed in Scilit:
- Inhibition of Non-Homologous End Joining Repair Impairs Pancreatic Cancer Growth and Enhances Radiation ResponsePLOS ONE, 2012
- Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cellsApoptosis, 2012
- TBC1D3, a Hominoid-Specific Gene, Delays IRS-1 Degradation and Promotes Insulin Signaling by Modulating p70 S6 Kinase ActivityPLOS ONE, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Role of Cholesterol in the Development and Progression of Breast CancerThe American Journal of Pathology, 2011
- The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast CancerCancer Research, 2010
- Gr-1+CD11b+ myeloid-derived suppressor cells: Formidable partners in tumor metastasisJournal of Bone and Mineral Research, 2010
- Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joiningBiochemical Journal, 2009
- HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and TumorigenicityCurrent Biology, 2007
- Protein Sensors for Membrane SterolsCell, 2006